KD Logo

Potential Price Increase for Nurix Therapeutics Inc (NRIX) After Recent Insider Activity

Nurix Therapeutics Inc’s recent filing unveils that its Chief Financial Officer van Houte Hans unloaded Company’s shares for reported $44878.0 on May 02 ’24. In the deal valued at $12.83 per share,3,499 shares were sold. As a result of this transaction, van Houte Hans now holds 68,333 shares worth roughly $1.02 million.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Then, Hansen Gwenn sold 2,007 shares, generating $24,169 in total proceeds. Upon selling the shares at $12.04, the Chief Scientific Officer now owns 39,601 shares.

Before that, Ring Christine sold 1,513 shares. Nurix Therapeutics Inc shares valued at $18,220 were divested by the Chief Legal Officer at a price of $12.04 per share. As a result of the transaction, Ring Christine now holds 19,838 shares, worth roughly $0.3 million.

A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early March with a ‘”an Overweight”‘ rating. Oppenheimer began covering NRIX with “an Outperform” recommendation on February 28, 2023. Morgan Stanley started covering the stock on October 11, 2022. It rated NRIX as “an Equal-weight”.

Price Performance Review of NRIX

On Tuesday, Nurix Therapeutics Inc [NASDAQ:NRIX] saw its stock jump 7.25% to $14.95. Over the last five days, the stock has gained 5.58%. Nurix Therapeutics Inc shares have risen nearly 44.86% since the year began. Nevertheless, the stocks have risen 44.58% over the past one year. While a 52-week high of $18.12 was reached on 04/11/24, a 52-week low of $4.22 was recorded on 01/29/24. SMA at 50 days reached $14.03, while 200 days put it at $9.65. A total of 1.49 million shares were traded, compared to the trading of 0.33 million shares in the previous session.

Levels Of Support And Resistance For NRIX Stock

The 24-hour chart illustrates a support level at 14.56, which if violated will result in even more drops to 14.18. On the upside, there is a resistance level at 15.27. A further resistance level may holdings at 15.60. The Relative Strength Index (RSI) on the 14-day chart is 58.50, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.88, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 7.85%. Stochastics %K at 77.15% indicates the stock is a holding.

Most Popular